Esperion Therapeutics, Inc. - Common Stock (ESPR)

Esperion Therapeutics is a biotechnology company focused on developing and commercializing innovative therapies for cardiovascular diseases

The company specializes in creating oral medications aimed at lowering cholesterol levels, with a particular emphasis on treating patients with elevated low-density lipoprotein cholesterol (LDL-C). Esperion's research and development efforts are centered around understanding the underlying mechanisms of heart disease and providing effective solutions that can significantly reduce cardiovascular risk. Through its commitment to scientific advancement and patient care, Esperion strives to enhance the treatment landscape for individuals with hyperlipidemia and related conditions.